Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-639
Closed -$74.2K 184
2023
Q1
$74.2K Buy
+639
New +$71.5K ﹤0.01% 177
2021
Q3
Sell
-10,620
Closed -$1.13M 247
2021
Q2
$1.13M Sell
10,620
-368
-3% -$35.3K 0.11% 179
2021
Q1
$987K Buy
+10,988
New +$1.03M 0.1% 184

Other funds holding DXCM

Meag Munich Ergo's DXCM Position: Q2 2023 in Review

Meag Munich Ergo sold out of DexCom (DXCM) in Q2 2023, closing a stake of 639 shares — an estimated $74.2K sold.

Meag Munich Ergo first reported a position in DXCM in Q1 2021 and held it in 3 quarters. The position peaked at $1.13M in Q2 2021. 954 funds tracked by Wall St. Rank hold DXCM as of Q2 2023.

  • Meag Munich Ergo reported no remaining DexCom position as of Q2 2023 after selling out during the quarter.
  • Meag Munich Ergo sold 639 DexCom shares in Q2 2023, an estimated $74.2K.
  • Meag Munich Ergo first reported a position in DexCom in Q1 2021 and held it in 3 quarters.
  • Meag Munich Ergo's DexCom position peaked at $1.13M in Q2 2021.
  • 954 funds tracked by Wall St. Rank held DexCom as of Q2 2023.

Based on Meag Munich Ergo's 13F filing for Q2 2023, filed 14 Jul 2023.